CoChat

Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index; 2 of the 77 sources its claims cite were checked for support.

Abstract

Leading biological hypotheses propose that biological changes may underlie major depressive disorder onset and relapse/recurrence. Here, we investigate if there is prospective evidence for biomarkers derived from leading theories. We focus on neuroimaging, gastrointestinal factors, immunology, neurotrophic factors, neurotransmitters, hormones, and oxidative stress. Searches were performed in Pubmed, Embase and PsychInfo for articles published up to 06/2019. References and citations of included articles were screened to identify additional articles. Inclusion criteria were having an MDD diagnosis as outcome, a biomarker as predictor, and prospective design search terms were formulated accordingly. PRISMA guidelines were applied. Meta-analyses were performed using a random effect model when three or more comparable studies were identified, using a random effect model. Our search resulted in 67,464 articles, of which 75 prospective articles were identified on: Neuroimaging (N = 24), Gastrointestinal factors (N = 1), Immunology (N = 8), Neurotrophic (N = 2), Neurotransmitters (N = 1), Hormones (N = 39), Oxidative stress (N = 1). Meta-analyses on brain volumes and immunology markers were not significant. Only cortisol (N = 19, OR = 1.294,p = 0.024) showed a predictive effect on onset/relapse/recurrence of MDD, but not on time until MDD onset/relapse/recurrence. However, this effect disappeared when studies including participants with a baseline clinical diagnosis were removed from the analyses. Other studies were too heterogeneous to compare. Thus, there is a lack of evidence for leading biological theories for onset and maintenance of depression. Only cortisol was identified as potential predictor for MDD, but results are influenced by the disease state. High-quality (prospective) studies on MDD are needed to disentangle the etiology and maintenance of MDD.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found scarce prospective evidence that leading biological biomarkers predict major depressive disorder onset, relapse, or recurrence. Only cortisol showed a small predictive effect, but it was confounded by baseline clinical depression, study quality, and possible publication bias.

Key findings

  • From 67,464 screened articles, 75 prospective studies were identified: neuroimaging (N = 24), gastrointestinal factors (N = 1), immunology (N = 8), neurotrophic factors (N = 2), neurotransmitters (N = 1), hormones (N = 39), and oxidative stress (N = 1).
  • Meta-analyses on brain volumes and immunology markers were not significant. Cortisol was the only significant predictor across comparable studies (N = 19, OR = 1.294, 95% CI [1.035–1.616], p = 0.024), but not for time until MDD onset/relapse/recurrence (HR = 1.011, 95% CI [0.963–1.040], p = 0.447).
  • The cortisol effect disappeared when studies including participants with a baseline clinical MDD diagnosis were removed; it also became nonsignificant after removing outliers or low-quality studies, and publication-bias correction led to a nonsignificant effect.
  • Only 38 studies excluded participants with baseline clinical MDD diagnosis, and most other biomarker findings were too heterogeneous or incidental to meta-analyze.

Methods

  • Systematic review and meta-analysis following PRISMA, with searches in PubMed, Embase, and PsychInfo up to June 2019; inclusion required a prospective design, MDD diagnosis as outcome, and a biomarker from leading biological models as predictor.
  • Random-effects meta-analyses were performed when three or more comparable studies were available, using odds ratio or risk ratio as summary effects; heterogeneity was assessed with Q-test and I², with sensitivity analyses, moderator analyses, and publication-bias assessment.
  • The review included 75 prospective studies; 3,267 participants developed MDD over follow-up (median 3 years), and mean study quality score was 6.3 (median 6, range 3–9).

Limitations

  • The paper states that included studies were often of poor quality, had small numbers of MDD cases at follow-up, and that neuroimaging studies used smaller samples than immunology and hormone studies.
  • The authors did not correct for multiple testing; they note that such a correction would eliminate the cortisol effect, suggesting it may be a false positive.
  • The paper states that heterogeneity was marked, many nonsignificant studies did not report sufficient data for meta-analysis, and this may have inflated odds ratios; results should be interpreted with caution.
  • Evident from the text: many biomarker domains had fewer than three comparable studies or highly heterogeneous methods, precluding meta-analysis and limiting conclusions about most proposed biomarkers.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0585-z

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Flow Diagram of systematic search for prospective studies of MDD overall biological searches combined [24]. See Supplementary material for flow charts per search
Fig. 1 Flow Diagram of systematic search for prospective studies of MDD overall biological searches combined [24]. See Supplementary material for flow charts per searchCC BY · PubMed Central
Fig. 2 Forest plot of a meta-analysis on studies investigating measures of cortisol before MDD onset, relapse or recurrence. Charles et al. [42] and Cosgriff et al. [48] are identified as outliers, and excluding them from analysis resulted in a nonsignificant effect
Fig. 2 Forest plot of a meta-analysis on studies investigating measures of cortisol before MDD onset, relapse or recurrence. Charles et al. [42] and Cosgriff et al. [48] are identified as outliers, and excluding them from analysis resulted in a nonsignificant effectCC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 4 Not valid · 43 Not checked · 86 Own results and interpretations

62 more claims

Create a free account to see all 134 claims and to verify the 75 references still open.

See all claims — free account
  • It may state two separate claims as one. 42
  • Probably not a substantial claim. 31
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 123 references

Cited by

See all 518

Metadata

Authors
Kennis, M., Gerritsen, L., van Dalen, M., Williams, A., Cuijpers, P., & Bockting, C.
Affiliations
  • Utrecht University (NL)
  • Amsterdam Public Health (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Bockting, Claudi
Venue
Molecular Psychiatry
Published
2019-11-19
Volume
25
Issue
2
Pages
321-338
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2990461417
Cited by
435
References
122
Citations by year
2026: 50 · 2025: 75 · 2024: 74 · 2023: 76 · 2022: 69 · 2021: 66 · 2020: 24 · 2019: 1
FWCI
5.13
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
Netherlands Institute for Advanced Study in the Humanities and Social Sciences
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, biomarkers, depression onset, relapse and recurrence, cortisol, neuroimaging, neurotrophic factors, neurotransmitters, hormones, oxidative stress, brain volume, etiology of depression
MeSH terms
Major Depressive Disorder, Humans, Hydrocortisone, Prospective Studies, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41380-019-0585-z
The paper
Kennis, M., Gerritsen, L., van Dalen, M., Williams, A., Cuijpers, P., & Bockting, C. (2020). Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Molecular Psychiatry. https://doi.org/10.1038/s41380-019-0585-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.